Mobidiag Ltd today announced the expansion of its distribution agreement with PerkinElmer’s Wallac Oy subsidiary to include distribution of the Amplidiag® product line in Israel and several countries in Africa (Botswana, Ghana, Ivory Coast, Kenya, Mauritius, Morocco, Mozambique, Nigeria, Rwanda, Senegal, Uganda).
Following the 36e Réunion interdisciplinaire de chimiothérapie anti-infectieuse (RICAI) in Paris at the end of 2016, the French magazine Biologiste infos has chosen to come back on 3 key presentations regarding Helicobacter pylori, and one of them is mentioning Mobidiag’s test Amplidiag® H. pylori+ClariR.
Mobidiag is proud to announce it has become a member of the British In Vitro Diagnostics Association (BIVDA).
Mobidiag Ltd today announced the expansion of its distribution agreement with PerkinElmer’s Wallac Oy subsidiary to include distribution of the Amplidiag® product line in Israel and several countries in Africa (Botswana, Ghana, Ivory Coast, Kenya, Mauritius, Morocco, Mozambique, Nigeria, Rwanda, Senegal, Uganda).
Following the 36e Réunion interdisciplinaire de chimiothérapie anti-infectieuse (RICAI) in Paris at the end of 2016, the French magazine Biologiste infos has chosen to come back on 3 key presentations regarding Helicobacter pylori, and one of them is mentioning Mobidiag’s test Amplidiag® H. pylori+ClariR.
Mobidiag is proud to announce it has become a member of the British In Vitro Diagnostics Association (BIVDA).
Following new European regulations, the new Amplidiag Bacterial GE allows discrimination between Shiga-toxin (Stx) gene variants Stx1 and Stx2 .
Mobidiag sera présent aux 18e Journées Nationales d’Infectiologie (JNI), qui se tiendront à Saint Malo, France, 21-23 juin, 2017.
Mobidiag will be attending the Mikrobiologiskt vårmöte och Infektionsveckan (Infection Week and Microbiology Spring Meeting), which will take place in Örlogsstaden Karlskrona, Sweden, May 16-19, 2017.
We are pleased to announce that Mobidiag’s Amplidiag® Stool Parasites test will be featured during the event in the presentation: “Real-time PCR procedure for Cryptosporidium spp. detection in human stools: a multi centric evaluation”.
In this article, Sakari Jokiranta, MD, PhD, specialist in clinical microbiology and medical director of United Medix Laboratories – a client of the group explains what makes Mobidiag’s Amplidiag® diagnostics solutions so unique.
Mobidiag Ltd. announced today that it has successfully completed a 3,99 million euros funding supported by the Finnish investment service company Kansalaisrahoitus Oy. Adding up to the loan of 15 million euros from the European Investment Bank (EIB), this new funding was completed before closing date by over 300 investors.
Mobidiag will be attending the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria, April 22 – 25, 2017. Attend oral presentation and poster sessions to learn more about our Amplidiag® IVD tests.
Mobidiag will be attending the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria, April 22 – 25, 2017.
Mobidiag Ltd today announced an agreement with AB ANALITICA, specialized in the development and the sale of diagnostic systems for professional use, for the distribution of the Amplidiag® product line.
Mobidiag Ltd today announced the opening of a new office in United Kingdom and the appointment of Stuart Cranmer as Managing Director to lead the business in one of the most strategic markets for Mobidiag.
Mobidiag sera présent au stand n°18 lors du congrès annuel des Sociétés Françaises de Parasitologie et de Mycologie Médicale (SFP / SFMM). L’évènement se tiendra à Toulouse – Centre P. Paul Riquet CHU Purpan, les 29-31 mars 2017.
Mobidiag Oy, suomalainen molekyylidiagnostiikan yritys julkisti tänään saaneensa 1,2 miljoonan lisärahoituksen Tekesiltä, suomalaiselta innovaatiotoiminnan rahoittajalta.